Why Are Healthcare Providers Investing in Point-of-Care Molecular...

added blog Health

2025-10-07 13:42:02 -

Why Are Healthcare Providers Investing in Point-of-Care Molecular Diagnostics Technologies?

The global market for point-of-care molecular diagnostics is expected to reach USD 7.09 billion by 2030, from USD 4.30 billion in 2025, with a CAGR of 10.5%. Growth is mainly driven by the increasing prevalence of infectious diseases and cancer, which boosts demand for rapid and accurate testing solutions. Additionally, there is a growing focus on decentralized diagnostics to facilitate quick...

0 Comments 0 Shares 100 Views 0 Reviews